Oramed Pharmaceuticals, Inc. (ORMP)
4.75
-0.04
(-0.84%)
USD |
NASDAQ |
Sep 25, 15:30
Oramed Pharmaceuticals Cash from Operations (TTM) : -5.811M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -5.811M |
| March 31, 2026 | -9.095M |
| December 31, 2025 | -9.699M |
| September 30, 2025 | -11.00M |
| June 30, 2025 | -16.08M |
| March 31, 2025 | -10.45M |
| December 31, 2024 | -8.406M |
| September 30, 2024 | -7.812M |
| June 30, 2024 | -1.287M |
| March 31, 2024 | -5.861M |
| December 31, 2023 | -9.934M |
| September 30, 2023 | -16.22M |
| June 30, 2023 | -17.81M |
| March 31, 2023 | -23.38M |
| December 31, 2022 | -27.63M |
| September 30, 2022 | -26.29M |
| June 30, 2022 | -29.74M |
| March 31, 2022 | -25.12M |
| August 31, 2021 | -21.47M |
| May 31, 2021 | -18.01M |
| February 28, 2021 | -15.59M |
| November 30, 2020 | -15.81M |
| August 31, 2020 | -12.65M |
| May 31, 2020 | -13.25M |
| February 29, 2020 | -13.90M |
| Date | Value |
|---|---|
| November 30, 2019 | -12.07M |
| August 31, 2019 | -13.21M |
| May 31, 2019 | -14.45M |
| February 28, 2019 | -14.44M |
| November 30, 2018 | -16.06M |
| August 31, 2018 | -14.66M |
| May 31, 2018 | -12.06M |
| February 28, 2018 | -10.61M |
| November 30, 2017 | -10.06M |
| August 31, 2017 | -5.831M |
| May 31, 2017 | 3.02M |
| February 28, 2017 | 3.151M |
| November 30, 2016 | 8.40M |
| August 31, 2016 | 4.655M |
| May 31, 2016 | -3.177M |
| February 29, 2016 | -1.866M |
| November 30, 2015 | -5.794M |
| August 31, 2015 | -4.946M |
| May 31, 2015 | -4.719M |
| February 28, 2015 | -4.840M |
| November 30, 2014 | -4.718M |
| August 31, 2014 | -4.068M |
| May 31, 2014 | -3.657M |
| February 28, 2014 | -3.671M |
| November 30, 2013 | -3.462M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Eli Lilly & Co. | 28.08B |
| Pfizer Inc. | 13.40B |
| Liquidia Corp. | 167.71M |
| Scilex Holding Co. | -17.27M |
| BioAge Labs, Inc. | -87.60M |